EKF Diagnostics Holdings PLC Result of AGM and Voting Results

RNS Number : 3987O

EKF Diagnostics Holdings PLC

14 May 2024

 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Result of AGM and Voting Results

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that at its Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.

 

The voting results of the AGM were as follows:

 

	For		Against		Withheld
Resolution	Votes	%	Votes	%	Votes
1	248,228,094	99.78%	547,604	0.22%	58,727,253
2	306,929,202	99.99%	17,611	0.01%	556,138
3	307,478,974	100.00%	13,855	0.00%	10,122
4	242,675,522	97.55%	6,098,796	2.45%	58,728,633
5	307,473,521	99.99%	19,308	0.01%	10,122
6	307,471,021	99.99%	21,808	0.01%	10,122
7	302,901,784	98.51%	4,594,167	1.49%	7,000
8	307,478,340	99.99%	16,355	0.01%	8,256
9	307,474,469	99.99%	16,029	0.01%	12,453
10*	305,495,468	99.35%	1,998,483	0.65%	9,000
11*	251,801,517	81.89%	55,692,434	18.11%	9,000
12*	247,115,598	83.20%	49,902,353	16.80%	10,485,000

 

*Special Resolutions

 

EKF Diagnostics Holdings plc		www.ekfdiagnostics.com
Julian Baines, Executive Chair / Stephen Young, CFO		via Walbrook PR
Singer Capital Markets (Nominated Adviser & Broker)			Tel: [phone]
Aubrey Powell / Oliver Platts
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus / Alice Woodings	Mob: [phone]

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

 

EKF is an AIM-listed global diagnostics business focussed on:

 

●	Point-of-Care analysers in the key areas of Hematology and Diabetes
●	Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

RAGQKQBDBBKDQPD